Primary Job Title Chairman & Board of Directors Primary Organization 
Ceterix Orthopaedics
Gender Male
Effective June 1, 2004, Kevin Sidow began his role as President and Chief Executive Officer for St. Francis Medical Technologies, Inc.
Prior to joining SFMT, Kevin was the Worldwide President of DePuy Inc. As former Worldwide President of DePuy, Kevin oversaw the global orthopedic, spine, trauma, and sports medicine businesses and has over 20
years of orthopedic medical device experience.
His responsibilities included the combined worldwide reconstructive business (hips, knee, extremities, operating room products, ACE and casting), Spine, Mitek (sports medicine) and Biologics with annual revenue responsibility of over $3 billion.
Kevin joined DePuy in March of 1998 as Midwest Area Vice President. He was promoted to Vice President, Sales, for DePuy Orthopaedics in October 1999 where he contributed significantly to the integration of the joints sales force while achieving record sales levels.
He was promoted to President of DePuy Orthopaedics in August 2000. In April 2001, he was promoted to Worldwide President, DePuy Orthopaedics, ACE and Casting. In September 2003 he advanced to the position of Worldwide President, DePuy Inc.
in addition to becoming a member of the MD&D Group Operating Committee. Prior to joining DePuy, Kevin was with Howmedica, then the orthopaedic division of Pfizer.
SFMT’s first product, the X STOP® Interspinous Process Decompression (IPD) System for treatment of lumbar spinal stenosis, provides a minimally invasive alternative for spinal decompression.
Founded in 1997, St. Francis Medical Technologies is a privately held company focused on developing innovative treatments for patients suffering from degenerative spinal disorders. Headquartered in Alameda, CA, the Company has raised a total of $28 million in venture capital to date.
In January 2007, St. Francis Medical Technologies, Inc. was sold for $725 million to Kyphon Inc.
